|
|
|
|
Report No. : |
514515.2 |
|
Report Date : |
21.06.2018 |
IDENTIFICATION DETAILS
|
Name : |
BHARATH MEDICAL AND GENERAL AGENCIES |
|
|
|
|
Registered
Office : |
No. 1980B, 1st & 2nd Floor, 26th Cross, 9th Main Road,
Bhansankari, Second Stage, Bangalore-560070, Karnataka |
|
Mobile No.: |
91-9448066469 [Mr. Babulal Chowhan] |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2018 [Sales Figures] 31.03.2017 [Detailed Financial] |
|
|
|
|
Year of
Establishment : |
1964 |
|
|
|
|
Capital
Investment : |
INR 6.241 Million [As on 31.03.2017] |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Applicable (As informed by the management that firm does not have export and import) |
|
|
|
|
TIN No.: |
29440306290 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AARPB6016G |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
29AARPB6016G1ZP |
|
|
|
|
Legal Form : |
Sole Proprietary Concern |
|
|
|
|
Line of Business
: |
Trader and Distributor of Pharmaceutical and Healthcare Products.
[Confirmed by Management] |
|
|
|
|
No. of Employees
: |
15 [Approximately] |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Maximum Credit Limit : |
USD 17800 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a proprietorship concern established in the year 1964. It is a trader and distributor of Pharmaceutical and Healthcare
products. Mr. Rajesh (Manager) has provided information about the subject and
further he claimed that the subject has achieved revenue of INR 350 million
for the FY 2018 (Which could not be verified). As per the financial records of 2017, the concern has reported decline
in its revenue as compared to previous year but has managed to maintain low
profit margin of 0.33%. The satisfactory financial profile of the concern is marked by
comfortable capital base along with average debt coverage indicators. Rating takes into consideration long established track record of the
concern. Business is active. Payment seems to be slow but correct. In view of aforesaid, the subject can be considered for business
dealings at usual trade terms and conditions. Note 1: Site Visit was
conducted at the given address and our executive has successfully traced the
subject. At the premises, our executive met Mr. Devendra (Security Guard) and
he confirmed that the subject is situated on the given address and further he
denied to provide any information and further he did not allow our executive
to enter in the premises. During the site visit, our executive enquired with neighbour companies
(Grid R & D and Yadava Samudaya Bhavana) and they confirmed that the subject
is situated on the given address. As per our executive’s observation, it is a 2 storey building and
entire premises belongs to subject. Location was easy to find and locality
appears to be commercial cum industrial. Area seems to be neutral. Name board of the subject was sighted. Note 2: As per the name
board of the subject sighted during the site visit the correct name of the
concern is “Bharath Medical and General Agencies”. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (31.12.2017) |
Current Rating (01.04.2018) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2018.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial Reconstruction)
list as of 21.06.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION PARTED BY
|
Name : |
Mr. Rajesh |
|
Designation : |
Manager |
|
Contact No.: |
91-9448066469 |
|
Date : |
13.06.2018 |
LOCATIONS
|
Registered Office : |
No. 1980B, 1st & 2nd Floor, 26th Cross, 9th Main Road,
Bhansankari, Second Stage, Bangalore-560070, Karnataka, India |
|
Tel. No.: |
91-80-26719500/ 600/ 800 |
|
Mobile No.: |
91-9448066469 [Mr. Babulal Chowhan] |
|
Fax No.: |
91-80-26719700 |
|
E-Mail : |
|
|
Website : |
|
|
Area : |
5700 Sq. Ft. |
|
Location : |
Rented |
|
Locality : |
Commercial |
SOLE PROPRIETOR
|
Name : |
Mr. Babulal Chowhan |
|
Designation : |
Proprietor |
|
Address : |
No. 33rd, “A” Cross, 4th Block, Jayanagar,
Bangalore-560011, Karnataka, India |
|
Date of Birth/Age : |
72 Years |
|
PAN No.: |
AARPB6016G |
KEY EXECUTIVES
|
Name : |
Mr. Rajesh |
|
Designation : |
Manager |
BUSINESS DETAILS
|
Line of Business : |
Trader and Distributor of Pharmaceutical and Healthcare Products.
[Confirmed by Management] |
|
|
|
|
Products/ Services : |
· Pharmaceutical · Healthcare Products |
|
|
|
|
Brand Names : |
Not Available |
|
|
|
|
Agencies Held : |
·
Smith & Nephew Healthcare Private Limited ·
Glaxo Smith Kline Pharmaceuticals Limited ·
MSD Pharmaceuticals Limited ·
Novartis India Limited |
|
|
|
|
Exports : |
|
|
Products : |
Not Available |
|
Countries : |
Not Available |
|
|
|
|
Imports : |
|
|
Products : |
Not Available |
|
Countries : |
Not Available |
|
|
|
|
Terms : |
|
|
Selling : |
Cheque and Credit [30,60 Days] and Others [RTGS] |
|
|
|
|
Purchasing : |
Cheque and Credit [30,60 Days] and Others [RTGS] |
GENERAL INFORMATION
|
Suppliers : |
·
Smith & Nephew Healthcare Private Limited ·
Glaxo Smith Kline Pharmaceuticals Limited ·
MSD Pharmaceuticals Limited |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
Wholesaler, Retailers and Others [Hospital]
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
15 [Approximately] |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Auditors : |
|
|
Name : |
Pranav Mehta and Associates Chartered Accountants |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Sister Concern : |
Rishabh Inc |
CAPITAL STRUCTURE
AS ON 31.03.2017
|
Capital Investment : |
|
|
Owned : |
INR 6.241 Million |
|
Borrowed : |
--- |
|
Total : |
INR 6.241
Million |
FINANCIAL ANALYSIS
[all figures are
in INR Million]
|
PARTICULARS |
|
|
31.03.2018 |
|
Sales Turnover (Approximately) |
|
|
350.000 |
|
|
|
|
|
Expected Sales (2018-2019): INR 500.000 Million [due to business growth]
The above information has been parted by Mr. Rajesh (Manager)
Note : Sole Proprietary and Partnership concerns are
exempted from filing their financials with the Government Authorities or
Registry Records.
FINANCIAL ANALYSIS
[all figures are
in INR Million]
Note : Sole Proprietary and Partnership concerns are
exempted from filing their financials with the Government Authorities or
Registry Records.
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Capital Account |
6.241 |
6.410 |
4.837 |
|
|
2] Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
6.241 |
6.410 |
4.837 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
13.493 |
22.811 |
8.674 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
13.493 |
22.811 |
8.674 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
19.734 |
29.221 |
13.511 |
|
|
|
|
|
|
|
|
APPLICATION OF
FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1.248 |
1.406 |
1.095 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERRED TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
15.795
|
15.136
|
12.647
|
|
|
Sundry Debtors |
50.202
|
57.329
|
59.443
|
|
|
Cash & Bank Balances |
1.462
|
1.343
|
0.860
|
|
|
Other Current Assets |
4.701
|
9.588
|
3.745
|
|
|
Loans & Advances |
10.723
|
6.239
|
9.063
|
|
Total
Current Assets |
82.883
|
89.635
|
85.758
|
|
|
Less :
CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
62.925
|
60.501
|
71.889
|
|
|
Other Current Liabilities |
0.975
|
0.848
|
0.944
|
|
|
Provisions |
0.497
|
0.471
|
0.509
|
|
Total
Current Liabilities |
64.397
|
61.820
|
73.342
|
|
|
Net Current Assets |
18.486
|
27.815
|
12.416 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
19.734 |
29.221 |
13.511 |
|
PROFIT
& LOSS ACCOUNT
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry Debtors / Income * 365 Days) |
50.98 |
52.84 |
59.85 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
7.16 |
6.91 |
6.10 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
67.36 |
58.51 |
76.10 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.79 |
0.83 |
0.94 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
9.98 |
8.96 |
10.90 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing + Current Liabilities) / Total Assets) |
0.93 |
0.93 |
0.94 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
2.16 |
3.56 |
1.79 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
10.32 |
9.64 |
15.16 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.20 |
0.22 |
0.23 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
1.14 |
1.16 |
1.14 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
0.33 |
0.36 |
0.33 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
1.41 |
1.57 |
1.36 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
19.07 |
22.31 |
24.48 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current Assets / Current Liabilities) |
1.29 |
1.45 |
1.17 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
1.04 |
1.21 |
1.00 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.07 |
0.07 |
0.06 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
2.16 |
3.56 |
1.79 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.29 |
1.45 |
1.17 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particulars |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Capital Account |
4.837 |
6.410 |
6.241 |
|
Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
Net
worth |
4.837 |
6.410 |
6.241 |
|
Secured Loans |
8.674 |
22.811 |
13.493 |
|
Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
8.674 |
22.811 |
13.493 |
|
Debt/Equity
ratio |
1.793 |
3.559 |
2.162 |
%2021-Jun-2018_files/image018.gif)
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
362.498 |
396.020 |
359.461 |
|
|
|
9.247 |
-9.232 |
%2021-Jun-2018_files/image020.gif)
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
362.498 |
396.020 |
359.461 |
|
Profit |
1.184 |
1.430 |
1.190 |
|
|
0.33% |
0.36% |
0.33% |
%2021-Jun-2018_files/image022.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
Yes |
|
5 |
Buyer visit details |
Yes |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
Yes |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last four years |
Yes |
|
27 |
Reasons for variation <> 20% |
Yes |
|
28 |
Estimation for coming financial year |
Yes |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
No |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter involved
in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
OBSERVATION POINTS
|
Name of Company : |
BHARATH MEDICAL AND GENERAL AGENCIES |
|
|
|
|
Address : |
No. 1980B, 1st & 2nd Floor, 26th Cross, 9th Main Road,
Bhansankari, Second Stage, Bangalore-560070, Karnataka, India |
|
|
|
|
Person to whom we met: |
Mr. Devendra (Security Guard) |
|
|
|
|
Name Board : |
Sighted |
|
|
|
|
Location: |
Easy |
|
|
|
|
Total Floors of the Building : |
2 Storey Building |
|
|
|
|
Subject situated on: |
Entire Premises Belongs to Subject |
|
|
|
|
Locality: |
Commercial cum Industrial |
|
|
|
|
Area : |
Neutral |
|
|
|
|
Neighbours Interview : |
During the site visit, our executive enquired with neighbour companies
(Grid R & D and Yadava Samudaya Bhavana) and they confirmed that the
subject is situated on the given address. |
|
|
|
|
Proof of visit: |
Photos |
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any
of its beneficial owners, controlling shareholders or senior officers as
terrorist or terrorist organization or whom notice had been received that all
financial transactions involving their assets have been blocked or convicted,
found guilty or against whom a judgement or order had been entered in a
proceedings for violating money-laundering, anti-corruption or bribery or
international economic or anti-terrorism sanction laws or whose assets were
seized, blocked, frozen or ordered forfeited for violation of money laundering
or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the
property or assets of the subject are derived from criminal conduct or a
prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No
record exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our
market survey revealed that the amount of compensation sought by the subject is
fair and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 68.08 |
|
|
1 |
INR 89.60 |
|
Euro |
1 |
INR 78.83 |
INFORMATION DETAILS
|
Information
Gathered by : |
SHA |
|
|
|
|
Analysis Done by
: |
VAR |
|
|
|
|
Report Prepared
by : |
IND |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a
reference to assess SC’s credit risk and to set the amount of credit to be
extended. It is calculated from a composite of weighted scores obtained from
each of the major sections of this report. The assessed factors are as follows:
·
Financial condition covering various ratios
·
Company background and operations size
·
Promoters / Management background
·
Payment record
·
Litigation against the subject
·
Industry scenario / competitor analysis
·
Supplier / Customer / Banker review (wherever
available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.